CIHR Operating Grant: SPOR & JDRF – ICT Multi-Year Grant
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: Thursday 9th, November 2017
External Deadline: Tuesday 14th, November 2017
Description
The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care.
Patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices. In support of this, SPOR adheres to a set of principles such as incorporating effective patient engagement and performance measurement as integral components of the initiative.
As part of SPOR, the Innovative Clinical Trials (iCT) initiative aims to build capacity and increase the intensity of iCT research. iCTs use designs that are alternative to traditional Randomized Controlled Trials with application in areas ranging from product development to health system improvement. iCT methods reduce the cost of conducting trials, reduce the amount of time needed to answer research questions, and increase the relevance of research findings to patients, health care providers and policy makers. Adopting these alternative designs can maximize the use of existing knowledge and data.
Moreover, this funding opportunity is focused on the type of innovative clinical trials that involve:
- comparative effectiveness research; and/or
- implementation science research.
Comparative effectiveness research compares two or more healthcare options already shown to be efficacious. The healthcare options could include diagnostics, drugs, medical devices, surgeries, complementary medicine, self-care or ways to deliver health care. The findings should be able to inform health-care decisions by providing evidence on the effectiveness, benefits, and harms of different health care options and other type of interventions.
Implementation science research examines interventions that are already shown to work under certain conditions and within certain contexts, which could be defined by demographic, biological, clinical, social, economic, geographic, or other factors. Implementation science aims to determine if these interventions can be adapted to other contexts, how should they be adapted and what are the longer term effects. In other words, implementation research seeks to understand what interventions work for whom and under what circumstances. It studies the factors that influence the full and effective use of interventions in practice, which could include affordability, adaptability, scalability and sustainability.
The current funding opportunity will be jointly funded by CIHR and JDRF. However, projects are able to secure additional partner resources, investments and contributions from other partner organizations to appropriately support the project’s scope.
JDRF’s goal is to progressively remove the impact and burden of type 1 diabetes (T1D) from people’s lives. This funding opportunity will focus on areas of research that will positively impact the care, treatment and outcomes for Canadians living with T1D.
For more information, please visit CIHR’s website